• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GERMANY ARCHITECT HAVAB IGM; IGM ANTI-HAV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GERMANY ARCHITECT HAVAB IGM; IGM ANTI-HAV Back to Search Results
Catalog Number 06C30-25
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow up report will be submitted when the evaluation is complete.This report is being filed on an international product, architect havab igm, list 6c30, that has a similar product distributed in the u.S., architect havab-m list 6l21.
 
Event Description
The customer observed a (b)(6) havab igm result on the architect i2000sr analyzer.The following data was provided: (b)(6); vidas 0.93 ((b)(6)), architect 0.11 and 0.11.(b)(6); vidas 1.07 ((b)(6)), architect 0.35 and 0.32.(b)(6); vidas 1.03 ((b)(6)), repeated on liaison as (b)(6), architect 0.88 and 0.89.(b)(6); vidas 0.58 ((b)(6)), repeated on liaison as (b)(6), architect 0.64 and 0.70.Per the package insert the interpretation of results is as follows: less than 0.80.Nonreactive (nr), 0.80 to 1.20 grayzone reactive (gz), greater than 1.20 reactive (r).There was no impact to patient management reported.
 
Manufacturer Narrative
Further investigation of the customer issue included a review of the complaint text, a search for similar complaints, review of instrument logs, a review of labeling and sensitivity testing.No adverse trend was identified for the customer's issue.Labeling was reviewed and found to be adequate.No patient sample was available for return, therefore, a retained kit of the complaint lot number, was tested in a sensitivity set-up and all control values met control specifications and were in the typical range.In addition, the clinical sensitivity was evaluated by testing one commercially available seroconversion panel.Sensitivity testing met all specifications.Based on all available information and abbott diagnostics' complaint investigation, no product deficiency was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT HAVAB IGM
Type of Device
IGM ANTI-HAV
Manufacturer (Section D)
ABBOTT GERMANY
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GERMANY
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
noemi romero-kondos, rn bsn
100 abbott park road
dept. 09b9, lccp1-3
abbott park, IL 60064-3537
224667-512
MDR Report Key6267879
MDR Text Key65461493
Report Number3002809144-2017-00002
Device Sequence Number1
Product Code LOL
Combination Product (y/n)N
Reporter Country CodeSZ
PMA/PMN Number
K063329
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 02/13/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/20/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/14/2017
Device Catalogue Number06C30-25
Device Lot Number70645LI00
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/08/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/10/2016
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Treatment
ARCHITECT I2000SR ANALYZER; LN 03M74-97, SN (B)(4)
-
-